Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice

Elena Iavnilovitch1, Robert D Cardiff, Bernd Groner

  • 1Institute of Animal Science, Agricultural Research Organization, Volcani Center, Bet-Dagan, Israel.

Insights

Signal transducers and activators of transcription 5 (Stat5) variants promote mammary tumors in mice. Different Stat5 forms influence tumor type and molecular markers, revealing multiple oncogenic pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Signal transducers and activators of transcription (Stat) proteins regulate cell growth and survival.
  • Stat family members are implicated in various cancers, including tumorigenesis.
  • The specific role of Stat5 in mammary gland cancer requires further investigation.

Purpose of the Study:

  • To investigate the role of Signal transducers and activators of transcription 5 (Stat5) in mammary tumorigenesis.
  • To analyze the impact of different Stat5 variants on tumor development and characteristics.
  • To explore the molecular mechanisms underlying Stat5-driven mammary tumors.

Main Methods:

  • Generation of transgenic mice with mammary-gland-specific expression of wild-type, constitutively active, and dominant-negative Stat5 variants.
  • Analysis of tumor incidence, latency, and histological phenotypes.
  • Assessment of molecular markers including translation initiation factor 4E (eIF4E), cyclin D1, activated Stat3, and estrogen receptor alpha (ERalpha).

Main Results:

  • Mammary-directed expression of Stat5 variants led to mammary tumors with up to 22% incidence and 8-12 month latency.
  • Undifferentiated carcinomas were associated with carboxyl-terminally truncated Stat5.
  • Papillary and micropapillary adenocarcinomas were linked to native and constitutively active Stat5, with altered eIF4E, cyclin D1, Stat3, and ERalpha expression.

Conclusions:

  • Both transactivating and dominant-negative Stat5 forms can contribute to oncogenesis through distinct mechanisms.
  • Stat5 plays a significant role in mammary tumorigenesis.
  • The transactivation function of Stat5 influences the differentiation state of mammary tumors.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...